Skip to content
Cultural Foundation
Author:
Matisse Pharmaceuticals
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
June 9, 2026
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
May 19, 2026